Radioactive materials used in nuclear medicine are the radioisotopes or drugs that are identified with radioisotopes. A radiopharmaceutical transfusion is one of diagnostic methods and a radiation value approved should be measured. The nuclear medicine images of diagnostic methods can be made by a gamma camera (γ-camera). In this article, we used MCNPX2.4 for internal dosimetry assessment when the 64Cu radiopharmaceutical is in brain, heart or breast for imaging or treatment.
[1] JN. Bryan, F. Jia, et al. Monoclonal antibodies for copper-64 PET dosimetry and radioimmunotherapy. Cancer Biol Ther. 11 (2011).
[2] KF. Eckerman, A. Endo. MIRD: Radionuclide data and decay schemes. Second ed. VA: Society of Nuclear Medicine. (2008).
[3] RW. Howell. Radiation spectra for Auger- electron emitting radionuclides: report No. 2 of AAPM Nuclear Medicine Task Group No. 6. Med Phys. (1992).
[4] Z. Cai, CJ. Anderson. Chelators for copper radionuclides in positron emission tomography radiopharmaceuticals. J Labeled Comp Radiopharm. (2014).
Amini, M., & Salehi, H. (2020). Estimation and calculation of radiation dose of copper-64 for nuclear medicine usage. Journal of Radiation Safety and Measurement, 9(4), 275-284.
MLA
Moharam Amini; Hamed Salehi. "Estimation and calculation of radiation dose of copper-64 for nuclear medicine usage", Journal of Radiation Safety and Measurement, 9, 4, 2020, 275-284.
HARVARD
Amini, M., Salehi, H. (2020). 'Estimation and calculation of radiation dose of copper-64 for nuclear medicine usage', Journal of Radiation Safety and Measurement, 9(4), pp. 275-284.
VANCOUVER
Amini, M., Salehi, H. Estimation and calculation of radiation dose of copper-64 for nuclear medicine usage. Journal of Radiation Safety and Measurement, 2020; 9(4): 275-284.
)